Nov 12, 2025 04:52PM Firefly Neuroscience (AIFF) Tops Q3 EPS by 20c

Jul 14, 2025 07:47AM Firefly secures commercial deal for brain analysis platform study

Jun 20, 2025 07:45AM Firefly Neuroscience (AIFF) Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients

May 5, 2025 07:45AM Firefly Neuroscience (AIFF) Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Mar 6, 2025 07:30AM Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Feb 21, 2025 08:00AM Firefly Neuroscience (AIFF) Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Feb 11, 2025 07:45AM Firefly Neuroscience (AIFF) Accepted into NVIDIA Connect Program

Jan 10, 2025 08:02AM Arrivo BioVentures (AIFF) Announces Positive Results from qEEG and BNA™ Study of SP-624 on Neural Brain Activity Related to Depression and Cognition

Dec 4, 2024 09:02AM Firefly Neuroscience (AIFF) Appoints Greg Lipschitz as Chairman

Oct 16, 2024 09:21AM Firefly Neuroscience (AIFF) Collaborates with Bright Minds Biosciences (DRUG) to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA Technology

Sep 20, 2024 09:04AM Firefly Neuroscience (AIFF) Advances AI-Driven BNA Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis

Sep 5, 2024 09:03AM Firefly Neuroscience (AIFF) Appoints Stella Vnook to its Board